Hosted on MSN2mon
Profits fall by 27% at Abbvie's Botox plant at WestportPre-tax profits at AbbVie's global production facility for Botox in Westport last year declined by 27% to $1.1bn (€1.04bn). New accounts filed by Allergan Pharmaceuticals Ireland UC show that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback